Q3 2024
Released Oct 29, 2024, after the close
10-Q filed Oct 30, 2024, 30 days after period end · 0001653477-24-000100
Q3 2024 · 10-Q
Revenue$333.80M$333.80M −25.2% vs Q3 2023−14.5% vs Q2 2024
Net Income-$107.20M-$107.20M N/M vs Q3 2023N/M vs Q2 2024
EPS Diluted-$2.94-$2.94 N/M vs Q3 2023N/M vs Q2 2024
Gross Profit$131,600,000+2.0%
Operating Income$110,200,000−0.2%
Operating Cash Flowderived$46,500,000−55.8%
Free Cash Flowderived$28,500,000−60.3%
Margins · derived
Gross margin39.4%+10.5 pt vs Q3 2023
Operating margin33.0%+8.3 pt vs Q3 2023
Net margin-32.1%−37.8 pt vs Q3 2023
What the release said
The release
Same quarter
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $333.80M | $446.00M | $482.00M | $376.80M |
| Net Income | -$107.20M | $25.20M | $75.40M | -$4.20M |
| EPS Diluted | -$2.94 | $0.69 | $1.98 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR